Europe Biopsy Guidance System Market Size & Outlook

The biopsy guidance system market in Europe is expected to reach a projected revenue of US$ 361.1 million by 2028. A compound annual growth rate of 5% is expected of Europe biopsy guidance system market from 2022 to 2028.
Revenue, 2021 (US$M)
$256.1
Forecast, 2028 (US$M)
$361.1
CAGR, 2022 - 2028
5%
Report Coverage
Europe

Europe biopsy guidance system market highlights

  • The Europe biopsy guidance system market generated a revenue of USD 256.1 million in 2021.
  • The market is expected to grow at a CAGR of 5% from 2022 to 2028.
  • In terms of segment, stereotactic guided biopsy was the largest revenue generating product in 2021.
  • Ultrasound Guided Biopsy is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2022 to 2028.


Europe data book summary

Market revenue in 2021USD 256.1 million
Market revenue in 2028USD 361.1 million
Growth rate5% (CAGR from 2021 to 2028)
Largest segmentStereotactic guided biopsy
Fastest growing segmentUltrasound Guided Biopsy
Historical data covered2016 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationStereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy
Key market players worldwideBecton Dickinson & Co, Hologic Inc, Utah Medical Products Inc, B. Braun, Argon Medical Devices, Boston Scientific Corp, Inrad Optics Inc, Cook Medical, Planmed


Other key industry trends

  • In terms of revenue, Europe region accounted for 26.4% of the global biopsy guidance system market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 226.9 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopsy Guidance System Market Companies

Name Profile # Employees HQ Website

Europe biopsy guidance system market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopsy guidance system market will help companies and investors design strategic landscapes.


Stereotactic guided biopsy was the largest segment with a revenue share of 39.71% in 2021. Horizon Databook has segmented the Europe biopsy guidance system market based on stereotactic guided biopsy, ultrasound guided biopsy, mri guided biopsy covering the revenue growth of each sub-segment from 2016 to 2028.


Reasons to subscribe to Europe biopsy guidance system market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe biopsy guidance system market databook

  • Our clientele includes a mix of biopsy guidance system market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biopsy guidance system market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biopsy guidance system market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe biopsy guidance system market size, by country, 2016-2028 (US$M)

Europe Biopsy Guidance System Market Outlook Share, 2021 & 2028 (US$M)

Europe biopsy guidance system market size, by country, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more